Serine protease 3 promotes progression of diffuse large b-cell lymphoma and serves as a novel prognostic predictor

HIGHLIGHTS

  • who: Lymphoma and colleagues from the Department of Hematology and Oncology, Taizhou First People`s Hospital, Taizhou City, China have published the Article: Serine Protease 3 Promotes Progression of Diffuse Large B-Cell Lymphoma and Serves as a Novel Prognostic Predictor, in the Journal: Disease Markers of 30/Dec/2022
  • what: The authors aimed to explore the expression profile of PRSS3 in DLBCL and investigate its clinical significance well detailed functions.
  • how: The authors conducted multivariate analysis using a Cox hazard regression model . Since clinical data indicated that PRSS3 may play critical roles . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?